SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA) : vimarsana.com

Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has received regulatory clearance by the Australian Therapeutic Goods Administration (TGA). The clearance of the company's flagship medical device by the regulatory body allows for the sale, use and further commercial testing of SeptiCyte RAPID throughout Australia to differentiate infection-positive (sepsis) from infection-negative systemic in

Related Keywords

Brisbane , Queensland , Australia , Australian , Biocarti Idylla , Biocartis Idylla , Adam Irwin , Scott Stachowiak , Richard Brandon , Maddie Stabinski , Rollie Carlson , Immunexpres Septicyte , European Union , Russo Partners , University Of Queensland , Linkedin , Immunexpress Inc , Principal Research , Associate Professor Adam Irwin , Principal Research Fellow , Leadership Fellow , Queensland Children , Immunexpres Chief Scientific Officer , Chief Executive Officer , Abacus Diagnostics , Rapid , Systemic Inflammation , Australian Therapeutic Goods Administration , Molecular Diagnostic Company , Atient , Regulatory Clearance , Post Response , Epsis ,